Safety profile of the SQ house dust mite sublingual immunotherapy-tablet in Japanese adult patients with house dust mite-induced allergic asthma: a randomized, double-blind, placebo-controlled phase I study

Autor: Yuriko Maekawa, Fumi Nemoto, Ryuji Azuma, Hisakuni Sekino, Miyuki Sakaguchi, Naoki Muramatsu, Kazuhiro Okamiya, Akihiko Tanaka, Minoru Kudo
Rok vydání: 2018
Předmět:
Pulmonary and Respiratory Medicine
Adult
Male
medicine.medical_specialty
Allergy
Maximum Tolerated Dose
Placebo
Severity of Illness Index
Drug Administration Schedule
law.invention
Double blind
03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
Double-Blind Method
Japan
immune system diseases
law
Reference Values
medicine
Immunology and Allergy
Animals
Humans
Sublingual immunotherapy
030212 general & internal medicine
Antigens
Dermatophagoides
Asthma
House dust mite
Sublingual Immunotherapy
biology
Dose-Response Relationship
Drug
business.industry
Pyroglyphidae
Allergic asthma
Middle Aged
medicine.disease
biology.organism_classification
Dermatology
respiratory tract diseases
Treatment Outcome
030228 respiratory system
Pediatrics
Perinatology and Child Health
Female
Patient Safety
business
Follow-Up Studies
Tablets
Zdroj: The Journal of asthma : official journal of the Association for the Care of Asthma. 56(12)
ISSN: 1532-4303
Popis: Objective: The SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet has demonstrated effective treatment of HDM-induced allergic asthma in patients 18 years or older in European ...
Databáze: OpenAIRE
Externí odkaz: